WallStreetZenWallStreetZen

NASDAQ: OPTN
Optinose Inc Stock Forecast, Predictions & Price Target

Analyst price target for OPTN

Based on 2 analysts offering 12 month price targets for Optinose Inc.
Min Forecast
$4.00+331.03%
Avg Forecast
$4.50+384.91%
Max Forecast
$5.00+438.79%

Should I buy or sell OPTN stock?

Based on 2 analysts offering ratings for Optinose Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OPTN stock forecasts and price targets.

OPTN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-18
lockedlocked$00.00+00.00%2024-03-18

1 of 1

Forecast return on equity

Is OPTN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is OPTN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

OPTN revenue forecast

What is OPTN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$90.9M+28%
Avg 2 year Forecast
$125.5M+76.84%
Avg 3 year Forecast
$154.9M+118.14%
OPTN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OPTN revenue growth forecast

How is OPTN forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
29.94%
Industry
9.04%
Market
10.23%
OPTN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OPTN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OPTN vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
OPTN$0.93$4.50+384.91%Strong Buy
CRDL$1.67N/AN/A
EBS$1.86$5.00+168.82%Strong Buy
INCR$2.59N/AN/A
ZOM$0.13N/AN/A

Optinose Stock Forecast FAQ

Is Optinose Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: OPTN) stock is to Strong Buy OPTN stock.

Out of 2 analysts, 1 (50%) are recommending OPTN as a Strong Buy, 1 (50%) are recommending OPTN as a Buy, 0 (0%) are recommending OPTN as a Hold, 0 (0%) are recommending OPTN as a Sell, and 0 (0%) are recommending OPTN as a Strong Sell.

If you're new to stock investing, here's how to buy Optinose stock.

What is OPTN's revenue growth forecast for 2024-2026?

(NASDAQ: OPTN) Optinose's forecast annual revenue growth rate of 29.94% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Optinose's revenue in 2024 is $70,987,000.On average, 3 Wall Street analysts forecast OPTN's revenue for 2024 to be $10,236,213,007, with the lowest OPTN revenue forecast at $9,560,753,174, and the highest OPTN revenue forecast at $10,671,499,330. On average, 3 Wall Street analysts forecast OPTN's revenue for 2025 to be $14,141,510,877, with the lowest OPTN revenue forecast at $11,623,406,533, and the highest OPTN revenue forecast at $15,737,448,078.

In 2026, OPTN is forecast to generate $17,444,459,894 in revenue, with the lowest revenue forecast at $13,833,633,672 and the highest revenue forecast at $20,727,920,160.

What is OPTN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OPTN) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is OPTN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year OPTN price target, the average OPTN price target is $4.50, with the highest OPTN stock price forecast at $5.00 and the lowest OPTN stock price forecast at $4.00.

On average, Wall Street analysts predict that Optinose's share price could reach $4.50 by Mar 18, 2025. The average Optinose stock price prediction forecasts a potential upside of 384.91% from the current OPTN share price of $0.93.

What is OPTN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OPTN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.